Skip to main content
. 2011 Nov 6;2(1):21–28. doi: 10.1007/s12348-011-0047-5

Fig. 2.

Fig. 2

Histogram annotated with percentage of respondents, and 95% confidence intervals, citing each reason for not prescribing specific immunomodulatory therapies. MTX methotrexate, MMF mycophenolate mofetil, AZA azathioprine, CSA cyclosporine, CTX cyclophosphamide, INF infliximab, ADA adalimumab